AML (Acute Myeloid Leukemia),Leukemia Molecular Profiling of IDH1-Mutated ND-AML Patients in AGILE Study Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia AML Long-term Outcomes After Allo-SCT With Decitabine and Venetoclax Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia Phase 3 Viale-a Study: Ven Plus Aza for AML Treatment Mar 23, 2023
AML (Acute Myeloid Leukemia),Leukemia ADMIRAL trial: Gilteritinib vs. Chemotherapy for FLT3-Mutated AML Transplant Outcomes Mar 23, 2023
CML (Chronic Myeloid Leukemia),Leukemia Asciminib Outperforms Bosutinib in Long-Term CML-CP Treatment Feb 27, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Improved Outcomes in High-Risk Relapsed B-ALL with Blinatumomab Feb 27, 2023
AML (Acute Myeloid Leukemia),Leukemia Oral Azacitidine for Long-Term AML Maintenance Therapy - Study Results Feb 27, 2023
AML (Acute Myeloid Leukemia),Leukemia Phase 3 Trial: Enasidenib vs Conventional Care For Elderly With IDH2-Mutant AML Feb 10, 2023
